Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a research note released on Monday morning. The brokerage issued a sell rating on the stock.

Ampio Pharmaceuticals Stock Performance

Shares of NYSE AMPE opened at $0.00 on Monday. The firm has a market capitalization of $2,497.00, a price-to-earnings ratio of 0.00 and a beta of 3.67. Ampio Pharmaceuticals has a 1-year low of $0.00 and a 1-year high of $7.47.

Ampio Pharmaceuticals Company Profile

(Get Free Report)

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.

Featured Stories

• Five stocks we like better than Ampio Pharmaceuticals
• 3 Tickers Leading a Meme Stock Revival
• Taiwan Semiconductor Soars on Earnings With More Room to Run
• The Top 3 Healthcare Dividend Stocks to Buy and Hold
• Is Lucid Group Nearing the Bottom? What Investors Should Know
• Compound Interest and Why It Matters When Investing
• 90% Gain Possible? Analysts Are Bullish on Joby Aviation